Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer’s disease families
暂无分享,去创建一个
M. Ilyas Kamboh | David A. Bennett | Bradley F. Boeve | Robert A. Sweet | Daniel J. Schaid | Thomas D. Bird | Tatiana M. Foroud | Richard Mayeux | Neill R. Graff-Radford | Alison M. Goate | Martin Farlow | D. Schaid | D. Bennett | R. Mayeux | B. Boeve | A. Goate | R. Sweet | T. Foroud | T. Bird | B. Vardarajan | M. Kamboh | D. Tsuang | K. Faber | R. Rosenberg | N. Graff-Radford | M. Farlow | R. Ottman | S. Barral | M. Medrano | R. Lantigua | Ruth Ottman | Sandra Barral | Rafael Lantigua | Roger Rosenberg | E. Weamer | Kelley M. Faber | Badri N. Vardarajan | Debby Tsuang | Dolly Reyes-Dumeyer | Martin Z. Medrano | Xinbing Wang | Mahmud Muhiedine Barmada | Elise A. Weamer | M. M. Barmada | D. Reyes‐Dumeyer | Xinbing Wang | Robert A. Sweet | D. Reyes-Dumeyer | David A. Bennett | T. D. Bird | Tatiana M. Foroud | M. M. Barmada
[1] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[2] M. Hamshere,et al. Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[3] B. Devlin,et al. Linkage analysis of Alzheimer disease with psychosis , 2002, Neurology.
[4] B. Devlin,et al. Neuregulin‐1 polymorphism in late onset Alzheimer's disease families with psychoses , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[5] W. Thies,et al. 2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.
[6] Yaakov Stern,et al. Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E , 2001, Neurobiology of Aging.
[7] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[8] O. Lopez,et al. Psychosis in Alzheimer's Disease in the National Alzheimer's Disease Coordinating Center Uniform Data Set: Clinical Correlates and Association with Apolipoprotein E , 2011, International journal of Alzheimer's disease.
[9] J. Pettegrew,et al. Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology , 2002, Neurobiology of Aging.
[10] G. Abecasis,et al. Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.
[11] C. Ha,et al. SNX26, a GTPase-activating Protein for Cdc42, Interacts with PSD-95 Protein and Is Involved in Activity-dependent Dendritic Spine Formation in Mature Neurons* , 2013, The Journal of Biological Chemistry.
[12] C. Spencer,et al. Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.
[13] S. Wisniewski,et al. Psychotic Symptoms in Alzheimer's Disease Are Not Associated With More Severe Neuropathologic Features , 2000, International Psychogeriatrics.
[14] R A Ophoff,et al. Expanding the range of ZNF804A variants conferring risk of psychosis , 2011, Molecular Psychiatry.
[15] R. Sweet,et al. Genetics of psychosis in Alzheimer's disease: a review. , 2010, Journal of Alzheimer's disease : JAD.
[16] N. Morton,et al. The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type. , 1956, American journal of human genetics.
[17] Alejandro A. Schäffer,et al. PSEUDOMARKER 2.0: efficient computation of likelihoods using NOMAD , 2014, BMC Bioinformatics.
[18] J. Cummings,et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. , 2000, The Journal of neuropsychiatry and clinical neurosciences.
[19] B. Devlin,et al. Heritability of psychosis in Alzheimer disease. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[20] S. Wisniewski,et al. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. , 1999, Archives of neurology.
[21] James T Becker,et al. Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study. , 2012, The American journal of psychiatry.
[22] Joseph A. Gogos,et al. Strong association of de novo copy number mutations with sporadic schizophrenia , 2008, Nature Genetics.
[23] Raul Urrutia,et al. KRAB-containing zinc-finger repressor proteins , 2003, Genome Biology.
[24] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[25] O L Lopez,et al. Genome-wide copy-number variation study of psychosis in Alzheimer's disease , 2015, Translational Psychiatry.
[26] D. Schaid,et al. Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzhei , 2014, JAMA neurology.
[27] R. Wilson,et al. Hallucinations, Cognitive Decline, and Death in Alzheimer’s Disease , 2006, Neuroepidemiology.
[28] E. Lander,et al. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.
[29] J. Ott. Computer-simulation methods in human linkage analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[30] Brian Lawlor,et al. Genome-wide Association Study of Alzheimer’s disease with Psychotic Symptoms , 2011, Molecular Psychiatry.
[31] C. Lyketsos,et al. Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates , 2000, International journal of geriatric psychiatry.
[32] E. Wijsman,et al. Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE , 2011, PLoS genetics.
[33] M. Albert,et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. , 2005, Archives of neurology.
[34] C. Woods,et al. WDR62 is associated with the spindle pole and is mutated in human microcephaly , 2010, Nature Genetics.
[35] D. Bennett,et al. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. , 2010, Brain : a journal of neurology.
[36] S. Bassett,et al. Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[37] A. Morris,et al. Transethnic Meta-Analysis of Genomewide Association Studies , 2011, Genetic epidemiology.
[38] J. L. Mack,et al. Behavior Rating Scale for Dementia: Development of Test Scales and Presentation of Data for 555 Individuals with Alzheimer's Disease , 1999, Journal of geriatric psychiatry and neurology.
[39] J. Manson,et al. Generalization of adiposity genetic loci to US Hispanic women , 2013, Nutrition & Diabetes.